Senior Analytical Transfer Scientist

Cellares is seeking an innovative and highly motivated Senior Analytical Transfer Scientist with expertise in method transfer, validation and development of bioanalytical methods to support the Cell therapy Analytical Science and Technology team. This individual will interface cross-functionally across the Quality control, Manufacturing Science and Technology, Quality, Analytical Development team, Regulatory and serve as the analytical subject matter expert (SME) in supporting product development and regulatory submission.  This individual will contribute significantly in method transfer activities, validation, method performance, reagent or critical reagent qualification of our advanced cell therapy analytical Cell Q platform.  

The primary focus of this position is to design and implement new cell therapy method validation, and to transfer and  drive continuous improvement of the Cellares analytical platform. The ideal candidate will be a technical leader and cross-functional collaborator with demonstrated expertise in developing robust autologous and allogeneic cell therapy methods. 

Candidates should also enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.